ClinicalTrials.gg
CompletedNCT03323684Updated May 1, 2018

Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-cholecystectomy Analgesia

An interventional study of Quadratus lumborum block Group (QL) and Transversus abdominis plane Group (TAP) in Laparoscopic Cholecystectomy, sponsored by Mansoura University. Completed at 2 sites in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-05-01.

Sponsored by Mansoura University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

In laparoscopic cholecystectomy, overall pain is a conglomerate of three different and clinically separate components: incisional pain (somatic pain) due to trocar insertion sites, visceral pain (deep intra abdominal pain), and shoulder pain due to peritoneal stretching and diaphragmatic irritation associated with carbon dioxide insufflation. Moreover, it has been hypothesized that intense acute pain after laparoscopic cholecystectomy may predict development of chronic pain (e.g., postlaparoscopic cholecystectomy syndrome). Without effective treatment, this ongoing pain may delay recovery, mandate inpatient admission, and thereby increase the cost of such care.

Recently, the uses of peripheral axial blocks that deliver local anesthetic into the transversus abdominis fascial plane have become popular for operations that involve incision(s) of the abdominal wall. Thus, the Transversus Abdominis plane (TAP) block has been shown to reduce perioperative opioid use in elective abdominal surgery, including open appendicectomy, laparotomy, and laparoscopic cholecystectomy. However, the efficacy of the TAP block is reportedly only reliable in providing analgesia below the umbilicus. The ultrasound-guided subcostal transversus abdominis (STA) block is a recently described variation on the TAP block which produces reliable supraumbilical analgesia. Deposition of local anesthetic in this plane has shown to block dermatomes T6 to T10 with an occasional spread to T12. This variant will be discussed in our study.

Currently, the Quadratus Lumborum block (QL block) is performed as one of the perioperative pain management procedures for all generations (pediatrics, pregnant, and adult) undergoing abdominal surgery. The local anesthetic injected via the approach of the posterior QL block ( QL 2 block ) can more easily extend beyond the TAP to the thoracic paravertebral space or the thoracolumbar plane, the posterior QL block entails a broader sensory-level analgesic and may generate analgesia from T7 to L1. Use of posterior QL block in laparoscopic cholecystectomy has not been investigated before and it is the variant that will be discussed in our study.

Read the detailed description

The aim of this study is to compare the analgesic efficacy of ultrasound guided posterior quadratus lumborum block and subcostal transversus abdominis plane block in laparoscopic cholecystectomy. The primary outcome will be assessment of postoperative opioid analgesic requirements. The secondary outcomes will include assessing intraoperative analgesic requirements, stress of trocar insertion and insufflation, postoperative visual analogue scale (VAS), length of stay at post-anesthesia care unit (PACU), time of first request to analgesia, incidence of nausea, and vomiting.

The study will hypothesize that quadratus lumborum block will be more superior than or equal to transversus abdominis block because it could cover all the dermatome segments from caudally L1 to cranially till T6 segments as the drug is expected to travel from the QL to the higher paravertebral spaces.

02

Conditions studied

  • Laparoscopic Cholecystectomy
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,115 studies on the registry; 184 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • American Physical Status I or II

Exclusion criteria

Exclusion Criteria:

  • Patient refusal.
  • Hematological diseases
  • bleeding disorders.
  • Coagulation abnormality.
  • Psychiatric diseases.
  • Local skin infection
  • sepsis at site of the block.
  • Known intolerance to the study drugs.
  • Body Mass Index > 40 Kg/m2.
  • Emergency laparoscopic cholecystectomy
  • if laparoscopic procedure converted to open.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
159 participants (actual)

Study arms

  • Experimental
    Quadratus lumborum block Group (QL)

    Quadratus lumborum block will be performed

    Other: Quadratus lumborum block Group (QL) · Drug: Paracetamol infusion · Drug: Ketorolac analgesia · Drug: fentanyl

  • Experimental
    Transversus abdominis plane Group (TAP)

    Subcostal transversus abdominis plane will be performed

    Other: Transversus abdominis plane Group (TAP) · Drug: Paracetamol infusion · Drug: Ketorolac analgesia · Drug: fentanyl

  • Experimental
    Control group (C)

    Postoperative analgesia will be accomplished with conjunction of paracetamol and ketorolac

    Other: Control group (C) · Drug: Paracetamol infusion · Drug: Ketorolac analgesia · Drug: fentanyl

Interventions

  • OtherQuadratus lumborum block Group (QL)

    20 mL of 0.375% isobaric bupivacaine for each side deposited at the posterior aspect of the quadratus lumborum muscle (QLB type 2) using ultrasound after induction of general anesthesia and 15 minutes before start of surgery

  • OtherTransversus abdominis plane Group (TAP)

    20 mL of 0.375% isobaric bupivacaine for each side using ultrasound after induction of general anesthesia and 15 minutes before start of surgery

  • OtherControl group (C)

    No intervention will be done

  • Paracetamol infusion (15 mg.kg) will be given by intravenous infusion after induction of general anesthesia.

  • DrugKetorolac analgesia

    In PACU Ketorolac 30 mg ampoule will be given by intravenous infusion to all cases and then every 8 hours.

  • With induction of general anaesthesia, fentanyl (1 microgram.kg) will be given. Intraoperatively, Fentanyl boluses (0.5 microgram.kg) will be given in case of increase in intraoperative mean arterial blood pressure or heart rate of more than 20% of baseline for longer than 5 minutes. Postoperatively, Fentanyl boluses (20 micrograms) will be given if VAS is more than 3 and it might be repeated after 30 minutes until VAS is ≤ 3.

06

What researchers measure

Primary outcomes

  1. Cumulative postoperative fentanyl consumption (total dose given in micrograms)

    Time frame: For 24 hours after surgery

Secondary outcomes

  1. Cumulative intraoperative fentanyl consumption (total dose given in micrograms)

    Cumulative use of fentanyl during intra-operative period

    Time frame: For 4 hours after start of anaesthesia

  2. Heart rate

    Changes in intra-operative heart rate values

    Time frame: For 4 hours after start of anaesthesia

  3. Mean arterial blood pressure (mmHg)

    Changes in intra-operative mean arterial blood pressure values

    Time frame: For 4 hours after start of anaesthesia

  4. Dermatomal distribution of the extent of the blockade will be assessed by pinprick method

    Assessment of dermatomal distribution of the block for evaluating the success or failure of the block

    Time frame: the first one hour after surgery

  5. Postoperative pain severity will be assessed using VAS

    The severity of postoperative pain will be measured and recorded by using the visual analogue scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain

    Time frame: For 24 hours after surgery

  6. Time for the first request to rescue analgesia (in minutes)

    Time for first request to rescue analgesia

    Time frame: For 24 hours after surgery

  7. length of stay at PACU (in minutes)

    Time frame: For 24 hours after surgery

  8. Incidence of postoperative nausea and vomiting

    Time frame: For 24 hours after surgery

07

Study locations

2 sites
  • Mansoura University, Faculty of Medicine
    Al Mansurah, DK 050, Egypt
  • Mansoura University
    Al Mansurah, DK 050, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03323684
Responsible party
Sponsor
First posted
Oct 27, 2017
Start date
Oct 1, 2017
Primary completion
Mar 1, 2018
Completion
Mar 15, 2018
Last update
May 1, 2018

Study contacts

Mohamed Y Makharita, MD
study chair · Professor of Anesthesia and Surgical Intensive Care

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion